November 25, 2015
Recommended Topic Related To:

Cutivate Ointment

"The US Food and Drug Administration (FDA) has approved a foam containing calcipotriene and betamethasone dipropionate (Enstilar, Leo Pharma Inc) for topical treatment of plaque psoriasis in adults 18 years of age and older, according to a "...

Cutivate Ointment


Patients using topical corticosteroids should receive the following information and instructions:

  1.  This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.
  2.  This medication should not be used for any disorder other than that for which it was prescribed.
  3.  The treated skin area should not be bandaged or otherwise covered or wrapped so as to be occlusive unless directed by the physician.
  4.  Patients should report to their physician any signs of local adverse reactions.
  5.  This medication should not be used on the face, underarms, or groin areas unless directed by a physician.
  6. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, contact the physician.

Last reviewed on RxList: 10/29/2008
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.